FGFR1 and pilocytic astrocytoma: In addition, a partial response was observed in a young adult FGFR1 N546K-mutant pilocytic astrocytoma patient treated with pemigatinib, an FGFR1/2/3/4 ATP-competitive inhibitor [125].